Blood Brain Barrier Defect: Clinical Trials

2 trials for Blood Brain Barrier Defect, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Active not recruiting 1, Completed 1

Follow Blood Brain Barrier Defect: new trials by email Literature Review of Blood Brain Barrier Defect trials Research Report on Blood Brain Barrier Defect

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Minocycline for Aneurysmal Subarachnoid Hemorrhage (MASH)
Minocyclin - Aneurysm, Ruptured, Vasospasm, Intracranial
Phase 2Active not recruitingUniversity of Southern California202019-07-012023-02-10
P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)
P03277, Gadobenate dimeglumine, MRI - CNS Lesion, Blood Brain Barrier Defect
Phase 2CompletedGuerbet3122016-06-012021-10-25

Narrower conditions

Aneurysm, Ruptured (1)  ·  Vasospasm, Intracranial (1)

Broader conditions

Aneurysm (1)  ·  Brain Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Nervous System Diseases (1)  ·  Vascular Diseases (1)

Interventions

Minocycline (1)  ·  gadobenic acid (1)  ·  gadopiclenol (1)

Sponsors

Guerbet (1)  ·  University of Southern California (1)

Countries

United States (2)  ·  Belgium (1)  ·  Czechia (1)  ·  Hungary (1)  ·  Italy (1)  ·  Mexico (1)  ·  Poland (1)  ·  South Korea (1)

Results publications

PMID 35349976